JP5016926B2 - 架橋したヒアルロナンおよび／またはハイランに由来する粘着性ゲル、その調製および使用法 - Google Patents

架橋したヒアルロナンおよび／またはハイランに由来する粘着性ゲル、その調製および使用法 Download PDF

Info

Publication number
JP5016926B2
JP5016926B2 JP2006547530A JP2006547530A JP5016926B2 JP 5016926 B2 JP5016926 B2 JP 5016926B2 JP 2006547530 A JP2006547530 A JP 2006547530A JP 2006547530 A JP2006547530 A JP 2006547530A JP 5016926 B2 JP5016926 B2 JP 5016926B2
Authority
JP
Japan
Prior art keywords
gel
solution
dvs
polymer
ipc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2006547530A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007519779A (ja
Inventor
アデルヤ ケイ． レシチナー
ポール エー． コノウィッツ
バレンチナ バシリーバ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of JP2007519779A publication Critical patent/JP2007519779A/ja
Application granted granted Critical
Publication of JP5016926B2 publication Critical patent/JP5016926B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2006547530A 2003-12-30 2004-12-30 架橋したヒアルロナンおよび／またはハイランに由来する粘着性ゲル、その調製および使用法 Expired - Lifetime JP5016926B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53342903P 2003-12-30 2003-12-30
US60/533,429 2003-12-30
PCT/US2004/043811 WO2005066215A1 (en) 2003-12-30 2004-12-30 Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011169777A Division JP5680501B2 (ja) 2003-12-30 2011-08-03 架橋したヒアルロナンおよび／またはハイランに由来する粘着性ゲル、その調製および使用法

Publications (2)

Publication Number Publication Date
JP2007519779A JP2007519779A (ja) 2007-07-19
JP5016926B2 true JP5016926B2 (ja) 2012-09-05

Family

ID=34748900

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006547530A Expired - Lifetime JP5016926B2 (ja) 2003-12-30 2004-12-30 架橋したヒアルロナンおよび／またはハイランに由来する粘着性ゲル、その調製および使用法
JP2011169777A Expired - Lifetime JP5680501B2 (ja) 2003-12-30 2011-08-03 架橋したヒアルロナンおよび／またはハイランに由来する粘着性ゲル、その調製および使用法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011169777A Expired - Lifetime JP5680501B2 (ja) 2003-12-30 2011-08-03 架橋したヒアルロナンおよび／またはハイランに由来する粘着性ゲル、その調製および使用法

Country Status (10)

Country Link
US (1) US20050142152A1 (enExample)
EP (1) EP1701981B1 (enExample)
JP (2) JP5016926B2 (enExample)
CN (1) CN100537606C (enExample)
AU (1) AU2004312532B2 (enExample)
BR (1) BRPI0418309B8 (enExample)
CA (1) CA2550718C (enExample)
IL (1) IL176465A (enExample)
MX (1) MXPA06007556A (enExample)
WO (1) WO2005066215A1 (enExample)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338433B2 (en) 2002-08-13 2008-03-04 Allergan, Inc. Remotely adjustable gastric banding method
EP2181655B1 (en) 2002-08-28 2016-12-07 Apollo Endosurgery, Inc. Fatigue-restistant gastric banding device
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
PT2399528E (pt) 2004-01-23 2013-02-26 Allergan Inc Banda gástrica regulável de uma só peça, que pode ser fixada de forma amovível
ATE444045T1 (de) 2004-03-08 2009-10-15 Allergan Medical S A Verschlusssystem für röhrenförmige organe
ATE517652T1 (de) 2004-03-18 2011-08-15 Allergan Inc Vorrichtung zur volumeneinstellung intragastraler ballons
DK1817347T3 (en) * 2004-11-24 2017-08-14 Albumedix As Process for Crosslinking Hyaluronic Acid with Divinyl Sulfone
ES2537751T3 (es) * 2004-12-30 2015-06-11 Genzyme Corporation Regímenes para viscosuplementación intraarticular
US8251888B2 (en) 2005-04-13 2012-08-28 Mitchell Steven Roslin Artificial gastric valve
US20070067045A1 (en) * 2005-09-19 2007-03-22 Ar2 Partners, Inc. Systems and methods for skin wrinkle removal
US7798954B2 (en) 2006-01-04 2010-09-21 Allergan, Inc. Hydraulic gastric band with collapsible reservoir
US8043206B2 (en) 2006-01-04 2011-10-25 Allergan, Inc. Self-regulating gastric band with pressure data processing
BRPI0708128A2 (pt) * 2006-03-02 2011-05-17 Novozymes Biopolymer As derivado de ácido hialurÈnico, processo para produção de um derivado de ácido hialurÈnico, composição, artigo cosmético, artigo sanitário, médico ou cirúrgico, cápsula ou microcápsula de medicamento, métodos para realizar procedimentos em oftalmologia, no tratamento de osteoartrite, e no tratamento de cáncer, para realizar administração transdérmica e dérmica de um agente farmacologicamente ativo, e administração dérmica de um cosmético, e para realizar procedimentos no tratamento de perda de cabelo ou calvìcie, métodos oftalmológico, de tratamento de osteoartrite, de uma ferida, e de perda de cabelo ou calvìcie, e, uso de um derivado de ácido hialurÈnico
FR2909560B1 (fr) 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
AU2008256819A1 (en) * 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US8658148B2 (en) 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
EP2818184B1 (en) 2007-11-16 2018-10-31 Allergan, Inc. Compositions and methods for treating Purpura
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
AU2015252122A1 (en) * 2008-08-04 2015-11-26 Allergan Industrie Sas Hyaluronic acid-based gels including anesthetic agents
US8450475B2 (en) * 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
JP5702723B2 (ja) 2008-09-04 2015-04-15 ザ ジェネラル ホスピタル コーポレイション 声帯および軟組織の増強および修復用ヒドロゲル
US8317677B2 (en) 2008-10-06 2012-11-27 Allergan, Inc. Mechanical gastric band with cushions
US20100305397A1 (en) * 2008-10-06 2010-12-02 Allergan Medical Sarl Hydraulic-mechanical gastric band
US20100185049A1 (en) 2008-10-22 2010-07-22 Allergan, Inc. Dome and screw valves for remotely adjustable gastric banding systems
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
US8390326B2 (en) * 2009-05-05 2013-03-05 William Marsh Rice University Method for fabrication of a semiconductor element and structure thereof
FR2945293B1 (fr) 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
US8790702B2 (en) * 2009-07-30 2014-07-29 Carbylan Therapeutics, Inc. Modified hyaluronic acid polymer compositions and related methods
US8273725B2 (en) * 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US8758221B2 (en) 2010-02-24 2014-06-24 Apollo Endosurgery, Inc. Source reservoir with potential energy for remotely adjustable gastric banding system
US8840541B2 (en) * 2010-02-25 2014-09-23 Apollo Endosurgery, Inc. Pressure sensing gastric banding system
WO2011109730A2 (en) 2010-03-04 2011-09-09 The General Hospital Corporation Methods and systems of matching voice deficits with a tunable mucosal implant to restore and enhance individualized human sound and voice production
US8586562B2 (en) 2010-03-12 2013-11-19 Allergan Industrie, Sas Fluid compositions for improving skin conditions
DK2550027T4 (da) 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
US20110270024A1 (en) 2010-04-29 2011-11-03 Allergan, Inc. Self-adjusting gastric band having various compliant components
US9028394B2 (en) 2010-04-29 2015-05-12 Apollo Endosurgery, Inc. Self-adjusting mechanical gastric band
US9044298B2 (en) 2010-04-29 2015-06-02 Apollo Endosurgery, Inc. Self-adjusting gastric band
US20110270025A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Remotely powered remotely adjustable gastric band system
US9074095B2 (en) * 2010-06-03 2015-07-07 Technology Innovation Momentum Fund (Israel) Limited Partnership Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof
US8517915B2 (en) 2010-06-10 2013-08-27 Allergan, Inc. Remotely adjustable gastric banding system
US8716204B2 (en) 2010-07-27 2014-05-06 Zimmer, Inc. Synthetic synovial fluid compositions and methods for making the same
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US20120059216A1 (en) 2010-09-07 2012-03-08 Allergan, Inc. Remotely adjustable gastric banding system
EP4616907A3 (en) 2010-11-08 2025-11-12 Allergan Industries, SAS Soft tissue filler
US8961393B2 (en) 2010-11-15 2015-02-24 Apollo Endosurgery, Inc. Gastric band devices and drive systems
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
ES2738208T3 (es) 2011-06-03 2020-01-20 Allergan Ind Sas Composiciones de relleno dérmico que incluyen antioxidantes
US20130096081A1 (en) * 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
RS62488B1 (sr) 2011-08-10 2021-11-30 Glycores 2000 Srl Unakrsno povezani hijaluronat male molekulske težine, otporan na razgradnju
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
HK1198124A1 (en) * 2011-09-14 2015-03-13 Sumit Paliwal Dermal filler compositions for fine line treatment
CN102558600A (zh) * 2011-12-01 2012-07-11 上海白衣缘生物工程有限公司 交联透明质酸海绵及其制备方法
US8876694B2 (en) 2011-12-07 2014-11-04 Apollo Endosurgery, Inc. Tube connector with a guiding tip
US8961394B2 (en) 2011-12-20 2015-02-24 Apollo Endosurgery, Inc. Self-sealing fluid joint for use with a gastric band
PL2861626T3 (pl) 2012-06-15 2019-05-31 Merz Pharma Gmbh & Co Kgaa Sposób przygotowywania kompozycji na bazie kwasu hialuronowego
US9579388B2 (en) 2012-11-29 2017-02-28 Rene Gauthier System and method for alleviating the appearance of scars and/or scar tissue
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
US20170080120A1 (en) * 2014-05-16 2017-03-23 Ulstrast, Inc. Phase-shifting formulations
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
PL3256179T3 (pl) 2015-02-13 2020-05-18 Allergan Industrie, Sas Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
JP6706632B2 (ja) * 2016-01-05 2020-06-10 デンカ株式会社 半月板変性治療用組成物
TW201832783A (zh) 2016-12-02 2018-09-16 法商賽諾菲公司 包含ｇｌｐ－１／胰高血糖素雙重激動劑、連接子和透明質酸的接合物
CN108250457A (zh) * 2017-05-08 2018-07-06 上海利康瑞生物工程有限公司 一种剪切粘度可控的双相交联透明质酸钠凝胶及其制备方法和制剂
US20190240335A1 (en) * 2018-02-07 2019-08-08 Promedon S.A. Biocompatible Hydrogel Compositions
CA3108125A1 (en) * 2018-08-07 2020-02-13 Merz Pharma Gmbh & Co. Kgaa Method for dynamic filtration of a cross-linked hydrogel
WO2022051060A1 (en) * 2020-09-01 2022-03-10 Orthogenrx, Inc. Crosslinking of non-animal-derived hyaluronic acid with divinyl sulfone
EP4448588A1 (en) 2022-01-11 2024-10-23 WiQo S.p.A. New hyaluronic acid derivatives as innovative fillers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4586865A (en) * 1982-12-09 1986-05-06 Hansen John C Rotatable discharge conveyor for a belly-dump trailer
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
DE3684887D1 (de) * 1985-11-29 1992-05-21 Biomatrix Inc Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
AU619760B2 (en) * 1987-12-10 1992-02-06 Genzyme Biosurgery Corporation Hylan preparation and method of recovery thereof from animal tissues
SE8900422D0 (sv) * 1989-02-08 1989-02-08 Pharmacia Ab Tvaerbundna hyaluronatgeler samt foerfarande foer framstaellning av dessa
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5246698A (en) * 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2349168C (en) * 1998-11-10 2009-01-06 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, method of its production and medical material containing it
US6521223B1 (en) * 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
DE60120372T2 (de) * 2000-03-24 2007-07-05 Genentech Inc., San Francisco Verwendung von insulin zur behandlung von knorpelkrankheiten

Also Published As

Publication number Publication date
JP2007519779A (ja) 2007-07-19
MXPA06007556A (es) 2006-08-31
BRPI0418309A (pt) 2007-05-02
EP1701981B1 (en) 2017-06-07
BRPI0418309B8 (pt) 2021-05-25
CA2550718A1 (en) 2005-07-21
US20050142152A1 (en) 2005-06-30
WO2005066215A1 (en) 2005-07-21
AU2004312532A1 (en) 2005-07-21
BRPI0418309B1 (pt) 2016-08-02
EP1701981A1 (en) 2006-09-20
JP2012025955A (ja) 2012-02-09
CA2550718C (en) 2013-11-05
IL176465A0 (en) 2006-10-05
CN100537606C (zh) 2009-09-09
CN1902232A (zh) 2007-01-24
IL176465A (en) 2013-07-31
AU2004312532B2 (en) 2010-05-20
JP5680501B2 (ja) 2015-03-04

Similar Documents

Publication Publication Date Title
JP5016926B2 (ja) 架橋したヒアルロナンおよび／またはハイランに由来する粘着性ゲル、その調製および使用法
US8524213B2 (en) Polymeric materials, their preparation and use
JP6063867B2 (ja) ジスルフィド結合架橋生体適合性高分子ヒドロゲルおよびこれを含む製剤
ES2248817T3 (es) Procedimiento de preparacion de particulas reticuladas de polimeros hidrosolubles, las particulas obtenidas y su utilizacion.
EP1753787B1 (en) Method of covalently linking hyaluronan and chitosan
CN107281549B (zh) 与多糖交联的蛋白质的制备和/或制剂
US8222399B2 (en) Photoreactive polysaccharide, photocrosslinked polysaccharide product and method of making same and medical materials made from the crosslinked polysaccharide
PT2572702E (pt) Hidrogel coesivo monofásico biodegradável
CN102348464A (zh) 可注射生物材料
CN119698309A (zh) 用于治疗关节疾病的水凝胶组合物
Ivanov Hyaluronic Acid-Based Biomaterials

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070913

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110207

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110506

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110803

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120523

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120611

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150615

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5016926

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term